Effects of enhanced education for patients with the Helicobacter pylori infection: A systematic review and meta‐analysis

Background Helicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor medication and therapy compliance, which makes it difficult to eradicate their infections. This points to the need for stronger educational inte...

Full description

Saved in:
Bibliographic Details
Published inHelicobacter (Cambridge, Mass.) Vol. 27; no. 2; pp. e12880 - n/a
Main Authors Zha, Jing, Li, Yue‐yue, Qu, Jun‐yan, Yang, Xiao‐xiao, Han, Zhong‐xue, Zuo, Xiuli
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.04.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Helicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor medication and therapy compliance, which makes it difficult to eradicate their infections. This points to the need for stronger educational interventions aimed at enhancing compliance, thus increasing the potential for treatment success. As such, this study conducted a meta‐analysis to clarify the effects of enhanced patient education (EPE) programs for H. pylori. Materials and Methods We searched electronic databases (PubMed, EMBASE, Web of Science, and Cochrane Library) for randomized controlled trials (RCTs) on health education for patients infected with H. pylori from inception to June 2021. The primary outcome was the eradication rate of H. pylori, while the secondary outcomes included the incidence of individual adverse symptoms, treatment compliance, clinical symptom remission after treatment, and patient satisfaction. We used the fixed or random‐effects model to pool the risk ratio (RR), with 95% confidence interval. We also conducted sensitivity and subgroup analyses. Results Our search returned seven relevant studies across a total of 1,433 patients. Compared with controls, EPE was significantly associated with improved H. pylori eradication rates (RR = 1.16, 95%CI: 1.04–1.29, p = 0.006) and patient compliance (RR = 1.48, 95%CI: 1.14–1.93, p = 0.003). A subgroup analysis also showed that EPE benefits were consistent across patients with different eradication programs, WeChat intervention plans, and intervention frequencies (p < 0.05). However, there were no significant differences in the total adverse effects, common side effects (diarrhea, nausea, abdominal pain, taste disorder, and skin rash), or discontinuation rate (p > 0.05). Conclusions Patient education is inexpensive, safe, and convenient. In this context, our findings suggest that enhanced educational interventions have positive effects on both the H. pylori eradication rate and adherence among infected patients, and thus constitute promising complements to clinical treatment regimens.
AbstractList Background Helicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor medication and therapy compliance, which makes it difficult to eradicate their infections. This points to the need for stronger educational interventions aimed at enhancing compliance, thus increasing the potential for treatment success. As such, this study conducted a meta‐analysis to clarify the effects of enhanced patient education (EPE) programs for H. pylori. Materials and Methods We searched electronic databases (PubMed, EMBASE, Web of Science, and Cochrane Library) for randomized controlled trials (RCTs) on health education for patients infected with H. pylori from inception to June 2021. The primary outcome was the eradication rate of H. pylori, while the secondary outcomes included the incidence of individual adverse symptoms, treatment compliance, clinical symptom remission after treatment, and patient satisfaction. We used the fixed or random‐effects model to pool the risk ratio (RR), with 95% confidence interval. We also conducted sensitivity and subgroup analyses. Results Our search returned seven relevant studies across a total of 1,433 patients. Compared with controls, EPE was significantly associated with improved H. pylori eradication rates (RR = 1.16, 95%CI: 1.04–1.29, p = 0.006) and patient compliance (RR = 1.48, 95%CI: 1.14–1.93, p = 0.003). A subgroup analysis also showed that EPE benefits were consistent across patients with different eradication programs, WeChat intervention plans, and intervention frequencies (p < 0.05). However, there were no significant differences in the total adverse effects, common side effects (diarrhea, nausea, abdominal pain, taste disorder, and skin rash), or discontinuation rate (p > 0.05). Conclusions Patient education is inexpensive, safe, and convenient. In this context, our findings suggest that enhanced educational interventions have positive effects on both the H. pylori eradication rate and adherence among infected patients, and thus constitute promising complements to clinical treatment regimens.
Helicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor medication and therapy compliance, which makes it difficult to eradicate their infections. This points to the need for stronger educational interventions aimed at enhancing compliance, thus increasing the potential for treatment success. As such, this study conducted a meta-analysis to clarify the effects of enhanced patient education (EPE) programs for H. pylori. We searched electronic databases (PubMed, EMBASE, Web of Science, and Cochrane Library) for randomized controlled trials (RCTs) on health education for patients infected with H. pylori from inception to June 2021. The primary outcome was the eradication rate of H. pylori, while the secondary outcomes included the incidence of individual adverse symptoms, treatment compliance, clinical symptom remission after treatment, and patient satisfaction. We used the fixed or random-effects model to pool the risk ratio (RR), with 95% confidence interval. We also conducted sensitivity and subgroup analyses. Our search returned seven relevant studies across a total of 1,433 patients. Compared with controls, EPE was significantly associated with improved H. pylori eradication rates (RR = 1.16, 95%CI: 1.04-1.29, p = 0.006) and patient compliance (RR = 1.48, 95%CI: 1.14-1.93, p = 0.003). A subgroup analysis also showed that EPE benefits were consistent across patients with different eradication programs, WeChat intervention plans, and intervention frequencies (p < 0.05). However, there were no significant differences in the total adverse effects, common side effects (diarrhea, nausea, abdominal pain, taste disorder, and skin rash), or discontinuation rate (p > 0.05). Patient education is inexpensive, safe, and convenient. In this context, our findings suggest that enhanced educational interventions have positive effects on both the H. pylori eradication rate and adherence among infected patients, and thus constitute promising complements to clinical treatment regimens.
Helicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor medication and therapy compliance, which makes it difficult to eradicate their infections. This points to the need for stronger educational interventions aimed at enhancing compliance, thus increasing the potential for treatment success. As such, this study conducted a meta-analysis to clarify the effects of enhanced patient education (EPE) programs for H. pylori.BACKGROUNDHelicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor medication and therapy compliance, which makes it difficult to eradicate their infections. This points to the need for stronger educational interventions aimed at enhancing compliance, thus increasing the potential for treatment success. As such, this study conducted a meta-analysis to clarify the effects of enhanced patient education (EPE) programs for H. pylori.We searched electronic databases (PubMed, EMBASE, Web of Science, and Cochrane Library) for randomized controlled trials (RCTs) on health education for patients infected with H. pylori from inception to June 2021. The primary outcome was the eradication rate of H. pylori, while the secondary outcomes included the incidence of individual adverse symptoms, treatment compliance, clinical symptom remission after treatment, and patient satisfaction. We used the fixed or random-effects model to pool the risk ratio (RR), with 95% confidence interval. We also conducted sensitivity and subgroup analyses.MATERIALS AND METHODSWe searched electronic databases (PubMed, EMBASE, Web of Science, and Cochrane Library) for randomized controlled trials (RCTs) on health education for patients infected with H. pylori from inception to June 2021. The primary outcome was the eradication rate of H. pylori, while the secondary outcomes included the incidence of individual adverse symptoms, treatment compliance, clinical symptom remission after treatment, and patient satisfaction. We used the fixed or random-effects model to pool the risk ratio (RR), with 95% confidence interval. We also conducted sensitivity and subgroup analyses.Our search returned seven relevant studies across a total of 1,433 patients. Compared with controls, EPE was significantly associated with improved H. pylori eradication rates (RR = 1.16, 95%CI: 1.04-1.29, p = 0.006) and patient compliance (RR = 1.48, 95%CI: 1.14-1.93, p = 0.003). A subgroup analysis also showed that EPE benefits were consistent across patients with different eradication programs, WeChat intervention plans, and intervention frequencies (p < 0.05). However, there were no significant differences in the total adverse effects, common side effects (diarrhea, nausea, abdominal pain, taste disorder, and skin rash), or discontinuation rate (p > 0.05).RESULTSOur search returned seven relevant studies across a total of 1,433 patients. Compared with controls, EPE was significantly associated with improved H. pylori eradication rates (RR = 1.16, 95%CI: 1.04-1.29, p = 0.006) and patient compliance (RR = 1.48, 95%CI: 1.14-1.93, p = 0.003). A subgroup analysis also showed that EPE benefits were consistent across patients with different eradication programs, WeChat intervention plans, and intervention frequencies (p < 0.05). However, there were no significant differences in the total adverse effects, common side effects (diarrhea, nausea, abdominal pain, taste disorder, and skin rash), or discontinuation rate (p > 0.05).Patient education is inexpensive, safe, and convenient. In this context, our findings suggest that enhanced educational interventions have positive effects on both the H. pylori eradication rate and adherence among infected patients, and thus constitute promising complements to clinical treatment regimens.CONCLUSIONSPatient education is inexpensive, safe, and convenient. In this context, our findings suggest that enhanced educational interventions have positive effects on both the H. pylori eradication rate and adherence among infected patients, and thus constitute promising complements to clinical treatment regimens.
BackgroundHelicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor medication and therapy compliance, which makes it difficult to eradicate their infections. This points to the need for stronger educational interventions aimed at enhancing compliance, thus increasing the potential for treatment success. As such, this study conducted a meta‐analysis to clarify the effects of enhanced patient education (EPE) programs for H. pylori.Materials and MethodsWe searched electronic databases (PubMed, EMBASE, Web of Science, and Cochrane Library) for randomized controlled trials (RCTs) on health education for patients infected with H. pylori from inception to June 2021. The primary outcome was the eradication rate of H. pylori, while the secondary outcomes included the incidence of individual adverse symptoms, treatment compliance, clinical symptom remission after treatment, and patient satisfaction. We used the fixed or random‐effects model to pool the risk ratio (RR), with 95% confidence interval. We also conducted sensitivity and subgroup analyses.ResultsOur search returned seven relevant studies across a total of 1,433 patients. Compared with controls, EPE was significantly associated with improved H. pylori eradication rates (RR = 1.16, 95%CI: 1.04–1.29, p = 0.006) and patient compliance (RR = 1.48, 95%CI: 1.14–1.93, p = 0.003). A subgroup analysis also showed that EPE benefits were consistent across patients with different eradication programs, WeChat intervention plans, and intervention frequencies (p < 0.05). However, there were no significant differences in the total adverse effects, common side effects (diarrhea, nausea, abdominal pain, taste disorder, and skin rash), or discontinuation rate (p > 0.05).ConclusionsPatient education is inexpensive, safe, and convenient. In this context, our findings suggest that enhanced educational interventions have positive effects on both the H. pylori eradication rate and adherence among infected patients, and thus constitute promising complements to clinical treatment regimens.
Author Zuo, Xiuli
Li, Yue‐yue
Han, Zhong‐xue
Qu, Jun‐yan
Yang, Xiao‐xiao
Zha, Jing
Author_xml – sequence: 1
  givenname: Jing
  surname: Zha
  fullname: Zha, Jing
  organization: Shandong University
– sequence: 2
  givenname: Yue‐yue
  surname: Li
  fullname: Li, Yue‐yue
  organization: Shandong University
– sequence: 3
  givenname: Jun‐yan
  surname: Qu
  fullname: Qu, Jun‐yan
  organization: Shandong University
– sequence: 4
  givenname: Xiao‐xiao
  surname: Yang
  fullname: Yang, Xiao‐xiao
  organization: Shandong University
– sequence: 5
  givenname: Zhong‐xue
  surname: Han
  fullname: Han, Zhong‐xue
  organization: Shandong University
– sequence: 6
  givenname: Xiuli
  orcidid: 0000-0001-9556-8771
  surname: Zuo
  fullname: Zuo, Xiuli
  email: zuoxiuli@sdu.edu.cn
  organization: Shandong University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35150600$$D View this record in MEDLINE/PubMed
BookMark eNp1kU2OEzEQhS00iPmBBRdAltjAomf8E3e72Y1GgSBFYgNry-2UFY_cdrDdRM2KI3BGToIzyWxGUJsqyd97Kte7RGchBkDoNSXXtNbNFvw1ZVKSZ-iCCsYbwTt5VmciebPgsj9HlznfE0IEX_Qv0DkXVJCWkAv0c2ktmJJxtBjCVgcDGwybyejiYsA2JryrI4SK7F3Z4rIFvALvTBy0KVCfZx-Twy4cfKrmA77Fec4FxqozOMEPB3uswwaPUPSfX7910H7OLr9Ez632GV6d-hX69nH59W7VrL98-nx3u24Mr19q-sXAW61NZ7k1tKUMhg6E7RhwIAZa01NYGEMG4ESwjgPTA-mZBW1lK5jgV-jd0XeX4vcJclGjywa81wHilBVrmWR939ED-vYJeh-nVPc9ULwTUraMVerNiZqGETZql9yo06wer1qBmyNgUsw5gVXGlYeDlqSdV5SoQ26q5qYecquK908Uj6b_Yk_ue-dh_j-oVsv1UfEXWgao8Q
CitedBy_id crossref_primary_10_1111_hel_13115
crossref_primary_10_1111_hel_13137
crossref_primary_10_1111_hel_13114
crossref_primary_10_1155_2022_4710964
crossref_primary_10_3390_antibiotics11121746
crossref_primary_10_4081_ijfs_2024_12176
crossref_primary_10_3389_fpubh_2023_1344212
crossref_primary_10_1111_hel_13078
crossref_primary_10_1111_hel_13055
crossref_primary_10_1177_17562848241258021
crossref_primary_10_3390_antibiotics13100965
crossref_primary_10_1002_ddr_22025
crossref_primary_10_1111_hel_12912
crossref_primary_10_1111_jgh_16348
crossref_primary_10_1111_hel_12938
crossref_primary_10_2147_JMDH_S419630
crossref_primary_10_1111_hel_13102
crossref_primary_10_3390_antibiotics12020191
crossref_primary_10_1111_hel_13048
crossref_primary_10_3389_fcimb_2022_1049279
crossref_primary_10_1136_gutjnl_2024_332640
crossref_primary_10_33003_fjs_2024_0806_2845
crossref_primary_10_1136_gutjnl_2021_325948
crossref_primary_10_3390_antibiotics12020346
crossref_primary_10_1111_hel_12989
crossref_primary_10_1186_s13099_023_00556_x
crossref_primary_10_3390_diagnostics13111918
Cites_doi 10.1001/jama.2012.3507
10.1136/gutjnl-2016-312288
10.11613/BM.2012.031
10.1186/s12929-018-0469-6
10.1016/0016-5085(92)90095-G
10.1056/NEJMra050100
10.1016/j.amjmed.2016.06.011
10.1259/bjr.20190389
10.1111/apt.12516
10.1111/apt.13497
10.1080/00332747.2016.1237753
10.1046/j.0306-5251.2001.01531.x
10.1016/j.canlet.2013.08.016
10.1111/j.1365-2036.2011.04887.x
10.1111/j.1572-0241.1999.00856.x
10.3748/wjg.v21.i39.11179
10.1155/2020/8972473
10.1111/jgh.15468
10.1136/bmj.315.7109.629
10.1053/j.gastro.2021.10.048
10.1177/1756283X09337342
10.1111/apt.14561
10.1080/00365521.2017.1413132
10.1053/j.gastro.2019.04.011
10.1080/0142159X.2019.1595557
10.2165/00003495-199754060-00002
10.1111/hel.12569
10.1053/j.gastro.2017.04.022
10.2307/2533446
10.1111/hel.12682
10.1111/hel.12832
10.1016/j.jclinepi.2009.06.005
10.1136/bmj.d5928
10.1111/hel.12475
ContentType Journal Article
Copyright 2022 John Wiley & Sons Ltd
2022 John Wiley & Sons Ltd.
Copyright © 2022 John Wiley & Sons Ltd
Copyright_xml – notice: 2022 John Wiley & Sons Ltd
– notice: 2022 John Wiley & Sons Ltd.
– notice: Copyright © 2022 John Wiley & Sons Ltd
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
C1K
K9.
7X8
DOI 10.1111/hel.12880
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
Education
EISSN 1523-5378
EndPage n/a
ExternalDocumentID 35150600
10_1111_hel_12880
HEL12880
Genre reviewArticle
Meta-Analysis
Systematic Review
Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China
– fundername: Taishan Scholars Program of Shandong Province and National Clinical Research Center for Digestive Diseases supporting technology project
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OB
1OC
29I
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
A8Z
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DTERQ
DU5
EAD
EAP
EBC
EBD
EBS
EDH
EJD
EMB
EMK
EMOBN
EST
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OBS
OIG
OVD
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7QL
C1K
K9.
7X8
ID FETCH-LOGICAL-c3880-94b36aac7f3fc1612eb7e5f72e3e0ce6c91e4cc0be305273e2ab092feaf865253
IEDL.DBID DR2
ISSN 1083-4389
1523-5378
IngestDate Fri Jul 11 09:18:23 EDT 2025
Fri Jul 25 10:36:09 EDT 2025
Mon Jul 21 06:06:26 EDT 2025
Tue Jul 01 00:54:47 EDT 2025
Thu Apr 24 23:10:50 EDT 2025
Wed Jan 22 16:26:48 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords meta-analysis
enhanced patient education
Helicobacter pylori
systematic review
eradication rate
Language English
License 2022 John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3880-94b36aac7f3fc1612eb7e5f72e3e0ce6c91e4cc0be305273e2ab092feaf865253
Notes Funding information
This study was supported by the National Natural Science Foundation of China (82070551 and 81770538), the Taishan Scholars Program of Shandong Province, and the National Clinical Research Center for Digestive Diseases supporting technology project (2015BAI13B07)
ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ObjectType-Undefined-4
ORCID 0000-0001-9556-8771
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hel.12880
PMID 35150600
PQID 2637588622
PQPubID 2034141
PageCount 11
ParticipantIDs proquest_miscellaneous_2628299715
proquest_journals_2637588622
pubmed_primary_35150600
crossref_citationtrail_10_1111_hel_12880
crossref_primary_10_1111_hel_12880
wiley_primary_10_1111_hel_12880_HEL12880
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate April 2022
2022-04-00
2022-Apr
20220401
PublicationDateYYYYMMDD 2022-04-01
PublicationDate_xml – month: 04
  year: 2022
  text: April 2022
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Helicobacter (Cambridge, Mass.)
PublicationTitleAlternate Helicobacter
PublicationYear 2022
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2021; 26
1997; 315
2009; 62
2019; 92
2002; 53
2005; 353
2016; 129
2017; 66
1992; 102
2011; 34
2017; 153
2018; 23
2016; 79
2018; 25
2018; 47
2012; 307
2014; 86
2021; 36
2022; 162
2020; 2020
2013; 38
1997; 54
2019; 41
2019; 24
2015; 21
2016; 43
2019; 157
2020; 25
1999; 94
2009; 2
1994; 50
2012; 22
2018; 53
2014; 345
2011; 343
e_1_2_8_28_1
e_1_2_8_29_1
e_1_2_8_24_1
e_1_2_8_25_1
e_1_2_8_26_1
e_1_2_8_27_1
Osipenko MF (e_1_2_8_14_1) 2014; 86
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_21_1
e_1_2_8_22_1
e_1_2_8_23_1
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_35_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_32_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_30_1
References_xml – volume: 66
  start-page: 6
  issue: 1
  year: 2017
  end-page: 30
  article-title: Management of infection‐the Maastricht V/Florence Consensus Report
  publication-title: Gut
– volume: 157
  start-page: 44
  issue: 1
  year: 2019
  end-page: 53
  article-title: Reconciliation of recent treatment guidelines in a time of increasing resistance to antibiotics
  publication-title: Gastroenterology
– volume: 50
  start-page: 1088
  issue: 4
  year: 1994
  end-page: 1101
  article-title: Operating characteristics of a rank correlation test for publication bias
  publication-title: Biometrics
– volume: 25
  start-page: 65
  issue: 1
  year: 2018
  article-title: pylori infection and extra‐gastroduodenal diseases
  publication-title: J Biomed Sci
– volume: 315
  start-page: 629
  issue: 7109
  year: 1997
  end-page: 634
  article-title: Bias in meta‐analysis detected by a simple, graphical test
  publication-title: BMJ (Clinical Research ed)
– volume: 24
  issue: 3
  year: 2019
  article-title: Twice daily short‐message‐based re‐education could improve eradication rate in young population: a prospective randomized controlled study
  publication-title: Helicobacter
– volume: 47
  start-page: 868
  issue: 7
  year: 2018
  end-page: 876
  article-title: Systematic review with meta‐analysis: the worldwide prevalence of Helicobacter pylori infection
  publication-title: Aliment Pharmacol Ther
– volume: 92
  issue: 1103
  year: 2019
  article-title: Artificial intelligence for precision education in radiology
  publication-title: Br J Radiol
– volume: 53
  start-page: 130
  issue: 2
  year: 2018
  end-page: 133
  article-title: Inappropriate treatment in Helicobacter pylori eradication failure: a retrospective study
  publication-title: Scand J Gastroenterol
– volume: 307
  start-page: 1959
  issue: 18
  year: 2012
  end-page: 1969
  article-title: Probiotics for the prevention and treatment of antibiotic‐associated diarrhea: a systematic review and meta‐analysis
  publication-title: JAMA
– volume: 62
  start-page: 1006
  issue: 10
  year: 2009
  end-page: 1012
  article-title: Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement
  publication-title: J Clin Epidemiol
– volume: 34
  start-page: 1255
  issue: 11–12
  year: 2011
  end-page: 1268
  article-title: Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough
  publication-title: Aliment Pharmacol Ther
– volume: 54
  start-page: 797
  issue: 6
  year: 1997
  end-page: 800
  article-title: Issues in patient compliance
  publication-title: Drugs
– volume: 22
  start-page: 276
  issue: 3
  year: 2012
  end-page: 282
  article-title: Interrater reliability: the kappa statistic
  publication-title: Biochem Med (Zagreb)
– volume: 353
  start-page: 487
  issue: 5
  year: 2005
  end-page: 497
  article-title: Adherence to medication
  publication-title: N Engl J Med
– volume: 102
  start-page: 493
  issue: 2
  year: 1992
  end-page: 496
  article-title: Factors influencing the eradication of with triple therapy
  publication-title: Gastroenterology
– volume: 129
  start-page: 1219.e1211
  issue: 11
  year: 2016
  end-page: 1219.e1219
  article-title: Online educational video improves bowel preparation and reduces the need for repeat colonoscopy within three years
  publication-title: Am J Med
– volume: 2020
  start-page: 8972473
  year: 2020
  article-title: Telephone‐based reeducation of drug administration for Eradication: a multicenter randomized controlled study
  publication-title: Gastroenterology Research and Practice
– volume: 36
  start-page: 2383
  issue: 9
  year: 2021
  end-page: 2388
  article-title: Clarithromycin versus furazolidone for naïve Helicobacter pylori infected patients in a high clarithromycin resistance area
  publication-title: J Gastroenterol Hepatol
– volume: 43
  start-page: 514
  issue: 4
  year: 2016
  end-page: 533
  article-title: Review article: the global emergence of antibiotic resistance
  publication-title: Aliment Pharmacol Ther
– volume: 38
  start-page: 1230
  issue: 10
  year: 2013
  end-page: 1235
  article-title: Randomised controlled trial: sequential vs. standard triple therapy for Helicobacter pylori infection in Chinese children‐a multicentre, open‐labelled study
  publication-title: Aliment Pharmacol Ther
– volume: 2
  start-page: 273
  issue: 5
  year: 2009
  end-page: 279
  article-title: Improving compliance with helicobacter pylori eradication therapy: when and how?
  publication-title: Therapeutic Advances in Gastroenterology
– volume: 94
  start-page: 811
  issue: 3
  year: 1999
  end-page: 815
  article-title: Enhancing compliance not a prerequisite for effective eradication of Helicobacter pylori: the HelP Study
  publication-title: Am J Gastroenterol
– volume: 41
  start-page: 976
  issue: 9
  year: 2019
  end-page: 980
  article-title: Artificial intelligence in medical education
  publication-title: Med Teach
– volume: 343
  year: 2011
  article-title: The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
  publication-title: BMJ
– volume: 53
  start-page: 163
  issue: 2
  year: 2002
  end-page: 171
  article-title: Management of Helicobacter pylori eradication–the influence of structured counselling and follow‐up
  publication-title: Br J Clin Pharmacol
– volume: 21
  start-page: 11179
  issue: 39
  year: 2015
  end-page: 11184
  article-title: Effects of daily telephone‐based re‐education before taking medicine on eradication: a prospective single‐center study from China
  publication-title: World J Gastroenterol
– volume: 79
  start-page: 358
  issue: 4
  year: 2016
  end-page: 363
  article-title: Mobile applications for mental health providers
  publication-title: Psychiatry
– volume: 86
  start-page: 27
  issue: 2
  year: 2014
  end-page: 31
  article-title: Patient compliance as one of the factors determining the efficiency of eradication therapy
  publication-title: Ter Arkh
– volume: 345
  start-page: 196
  issue: 2
  year: 2014
  end-page: 202
  article-title: Helicobacter pylori‐induced gastric inflammation and gastric cancer
  publication-title: Cancer Lett
– volume: 23
  issue: 2
  year: 2018
  article-title: Fifth Chinese National Consensus Report on the management of infection
  publication-title: Helicobacter
– volume: 25
  issue: 2
  year: 2020
  article-title: Application of a social media platform as a patient reminder in the treatment of
  publication-title: Helicobacter
– volume: 153
  start-page: 420
  issue: 2
  year: 2017
  end-page: 429
  article-title: Global Prevalence of Helicobacter pylori Infection: systematic Review and Meta‐Analysis
  publication-title: Gastroenterology
– volume: 26
  issue: 5
  year: 2021
  article-title: Application of WeChat platform in the management of patients infected with
  publication-title: Helicobacter
– volume: 162
  start-page: 32
  issue: 1
  year: 2022
  end-page: 37
  article-title: How we approach difficult to eradicate
  publication-title: Gastroenterology
– ident: e_1_2_8_34_1
  doi: 10.1001/jama.2012.3507
– ident: e_1_2_8_8_1
  doi: 10.1136/gutjnl-2016-312288
– ident: e_1_2_8_19_1
  doi: 10.11613/BM.2012.031
– ident: e_1_2_8_3_1
  doi: 10.1186/s12929-018-0469-6
– volume: 86
  start-page: 27
  issue: 2
  year: 2014
  ident: e_1_2_8_14_1
  article-title: Patient compliance as one of the factors determining the efficiency of eradication therapy
  publication-title: Ter Arkh
– ident: e_1_2_8_15_1
  doi: 10.1016/0016-5085(92)90095-G
– ident: e_1_2_8_29_1
  doi: 10.1056/NEJMra050100
– ident: e_1_2_8_31_1
  doi: 10.1016/j.amjmed.2016.06.011
– ident: e_1_2_8_36_1
  doi: 10.1259/bjr.20190389
– ident: e_1_2_8_33_1
  doi: 10.1111/apt.12516
– ident: e_1_2_8_11_1
  doi: 10.1111/apt.13497
– ident: e_1_2_8_32_1
  doi: 10.1080/00332747.2016.1237753
– ident: e_1_2_8_24_1
  doi: 10.1046/j.0306-5251.2001.01531.x
– ident: e_1_2_8_2_1
  doi: 10.1016/j.canlet.2013.08.016
– ident: e_1_2_8_12_1
  doi: 10.1111/j.1365-2036.2011.04887.x
– ident: e_1_2_8_23_1
  doi: 10.1111/j.1572-0241.1999.00856.x
– ident: e_1_2_8_26_1
  doi: 10.3748/wjg.v21.i39.11179
– ident: e_1_2_8_28_1
  doi: 10.1155/2020/8972473
– ident: e_1_2_8_7_1
  doi: 10.1111/jgh.15468
– ident: e_1_2_8_21_1
  doi: 10.1136/bmj.315.7109.629
– ident: e_1_2_8_9_1
  doi: 10.1053/j.gastro.2021.10.048
– ident: e_1_2_8_13_1
  doi: 10.1177/1756283X09337342
– ident: e_1_2_8_5_1
  doi: 10.1111/apt.14561
– ident: e_1_2_8_30_1
  doi: 10.1080/00365521.2017.1413132
– ident: e_1_2_8_10_1
  doi: 10.1053/j.gastro.2019.04.011
– ident: e_1_2_8_35_1
  doi: 10.1080/0142159X.2019.1595557
– ident: e_1_2_8_16_1
  doi: 10.2165/00003495-199754060-00002
– ident: e_1_2_8_27_1
  doi: 10.1111/hel.12569
– ident: e_1_2_8_4_1
  doi: 10.1053/j.gastro.2017.04.022
– ident: e_1_2_8_22_1
  doi: 10.2307/2533446
– ident: e_1_2_8_25_1
  doi: 10.1111/hel.12682
– ident: e_1_2_8_17_1
  doi: 10.1111/hel.12832
– ident: e_1_2_8_18_1
  doi: 10.1016/j.jclinepi.2009.06.005
– ident: e_1_2_8_20_1
  doi: 10.1136/bmj.d5928
– ident: e_1_2_8_6_1
  doi: 10.1111/hel.12475
SSID ssj0005349
Score 2.4532037
SecondaryResourceType review_article
Snippet Background Helicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor...
Helicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor medication and...
BackgroundHelicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor...
Helicobacter pylori (H. pylori) infections are of serious concern due to the associated risk of gastric cancer. However, many patients have poor medication and...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e12880
SubjectTerms Anti-Bacterial Agents - pharmacology
Clinical trials
Confidence intervals
Diarrhea
Drug Therapy, Combination
Education
enhanced patient education
Eradication
eradication rate
Gastric cancer
Helicobacter Infections - diagnosis
Helicobacter pylori
Humans
Meta-analysis
Nausea
Patient education
Patient satisfaction
Patients
Remission
Side effects
Stomach Neoplasms - drug therapy
Subgroups
systematic review
Taste disorders
Title Effects of enhanced education for patients with the Helicobacter pylori infection: A systematic review and meta‐analysis
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fhel.12880
https://www.ncbi.nlm.nih.gov/pubmed/35150600
https://www.proquest.com/docview/2637588622
https://www.proquest.com/docview/2628299715
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VlUBceJTXloIGxKGXrDZ2XoZThVqtEOWAqNQDUmQ7YxVRshW7e2hP_AR-I7-EGedRykNC3CLFcRJ7xvPNePwNwHMzc2WTUZFoa7Iks02ZGO2rJGRBpV6zQSCJdxy-LeZH2evj_HgDXg5nYTp-iDHgJpoR12tRcOuWPyn5CZ1OeXGtxF-XXC0BRO8uqaNyHaFvyhAjkQrfPauQZPGMT161Rb8BzKt4NRqcg1vwYfjULs_k03S9clN_8QuL43_-y2242QNR3Osk5w5sULsF17rSlOdbcP2w33S_Cxcdw_ESFwGpPYkpA0hDYggy6sWenXWJEtZFxpTI5oxlzEUuaDyTqMBHHBK_2he4h5cU0tgdn0HbNviZVvb712-2p0q5B0cH--9fzZO-ZEPihVUmMZnThbW-DDp4BpOKXEl5KBVpmnkqvEkp837miNcZRk6krJsZFciGqshVru_DZrto6SFg2rgg5GFVyLhXY51qlKly41h6AqVmArvD5NW-5zOXshqn9eDX8KjWcVQn8GxsetaRePyp0c4gAXWvx8taFZodKvb61ASejrdZA2Vbxba0WEsb2Y02ZZpP4EEnOeNbdB4ZHLnz3Tj_f399Pd9_Ey-2_73pI7ih5DRGTCTagc3VlzU9Zoy0ck-iMvwAzbUOUw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRTwuPAqFLQUGxKGXrDZ2Xq64VNBqgd0eUCv1giLbGauIkq3Y3QM99SfwG_klHTuPUh4S4hYpjp04M55vxuNvAF6qkcmrhLJIapVEia7ySElbRC5xIraSDQL5eMd0PxsfJu-O0qMVeNWdhWn4IfqAm9eMsF57BfcB6Z-0_JhOhry6FuywX_MVvT1z_psPl-RRqQzgN2aQEfka3y2vkM_j6R-9ao1-g5hXEWswOXt34GP3sk2myefhcmGG9uwXHsf__Zq7cLvForjTCM89WKF6Da431Sm_rcGNabvvfh_OGpLjOc4cUn0csgaQutwQZOCLLUHrHH1kFxlWIls0FjMT6KDx1AcGPmGX-1Vv4w5eskhjc4IGdV3hF1roH-ffdcuW8gAO93YPXo-jtmpDZD2xTKQSIzOtbe6ks4wnBZmcUpcLkjSylFkVU2LtyBAvNQyeSGgzUsKRdkWWilSuw2o9q-kRYFwZ5_nDCpdwr0obUQlVpMqwADmK1QC2ur9X2pbS3FfWOCk714ZntQyzOoAXfdPThsfjT402OxEoW1WelyKT7FOx4ycG8Ly_zUrod1Z0TbOlb-M3pFUepwN42IhOP4pMA4kjd74VBODvw5fj3Um42Pj3ps_g5vhgOiknb_ffP4Zbwh_OCHlFm7C6-LqkJwyZFuZp0IwLnwQSbw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5Vrai4UFpe25ZiEIdeskps52E4VbSrBdoKISr1gBTZzlhFlOyqu3ugJ35CfyO_hLHzKOUhIW6R4jiJPeP5Zjz-BuC5ik1eScwioZWMpK7ySAlbRE46nlhBBgF9vOPoOBufyDen6ekSvOzOwjT8EH3AzWtGWK-9gk8r95OSn-H5kBbXgvz1FZnFytdt2H9_zR2VioB9E8IYkS_x3dIK-TSe_tGbxug3hHkTsAaLM1qDj923Nokmn4eLuRnay19oHP_zZ-7CnRaJsr1GdNZhCesNuNXUpvy6AatH7a77PbhsKI5nbOIY1mchZ4BhlxnCCPaylp51xnxclxGoZGTPSMhMIINmUx8W-MS6zK_6Bdtj1xzSrDk_w3RdsS8419-_XemWK-U-nIwOPrwaR23Nhsh6WplISSMyrW3uhLOEJjmaHFOXcxQYW8ysSlBaGxukhYagE3JtYsUdaldkKU_FA1iuJzU-ApZUxnn2sMJJ6lVpwyuuilQZEh-HiRrAbjd5pW0JzX1djfOyc2xoVMswqgN41jedNiwef2q03UlA2SryrOSZII-K3D4-gKf9bVJBv6-ia5wsfBu_Ha3yJB3Aw0Zy-reINFA4Uue7Yf7__vpyfHAYLjb_vekTWH23PyoPXx-_3YLb3J_MCElF27A8v1jgY8JLc7MT9OIHYg0RHg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+enhanced+education+for+patients+with+the+Helicobacter+pylori+infection%3A+A+systematic+review+and+meta-analysis&rft.jtitle=Helicobacter+%28Cambridge%2C+Mass.%29&rft.au=Zha%2C+Jing&rft.au=Li%2C+Yue-Yue&rft.au=Qu%2C+Jun-Yan&rft.au=Yang%2C+Xiao-Xiao&rft.date=2022-04-01&rft.issn=1523-5378&rft.eissn=1523-5378&rft.volume=27&rft.issue=2&rft.spage=e12880&rft_id=info:doi/10.1111%2Fhel.12880&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1083-4389&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1083-4389&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1083-4389&client=summon